Abstract
BackgroundTofacitinib is an oral Janus kinase (JAK) inhibitor for the treatment of psoriatic arthritis (PsA). Cytokines involved in lymphocyte development, function and homeostasis signal through JAKs, and reductions in mean...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have